Company Information

CIN
Status
Date of Incorporation
17 May 2021
State / ROC
Telangana / ROC Hyderabad
Industry
Sub Category
Last Balance Sheet
Last Annual Meeting
Paid Up Capital
0
Authorised Capital
0

Past Directors

Patents

Novel Naproxen Sodium Preparations For Parenteral Administration

Enclosed

Novel Liquid Oral Formulations Of Cannabidiol

The present invention relates to stable liquid oral pharmaceutical formulations of cannabidiol (CBD). The invention further discloses methods of producing a stabilized formulation of cannabidiol using cannabidiol from a synthetic source.

Solubilized Formulations Of Atorvastatin Calcium

Enclosed

Novel Omega 3 Carrier Preparations For Inhalation Drug Delivery For Treating Lung Inflammation

ABSTRACT Inflammatory disorders of the lung are induced by COVID-19 disease, asthma, and numerous other disorders. Omega-3 fatty acids (03FA ), particularly docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) or eicosapentaenoic acid (EPA), have known anti-inflammatory and pro-resolving properties. RedĂșction of...

Novel Parenteral Formulations Of Cannabidiol

Enclosed

Liquid Parenteral Formulations Of Bilastine Free Of Cyclodextrins

The present invention relates to liquid pharmaceutical formulations of bilastine and a process of preparing such formulations.these formulations are used to treat conditions caused by allergens or foreign substances.

Liquid Parenteral Formulations Of Bilastine

The present invention relates to liquid pharmaceutical formulations of bilastine and a process of preparing such formulations.these formulations are used to treat conditions caused by allergens or foreign substances.

Stable Formulations Of Bilastine For Nasal And Ophthalmic Use

Enclosed

Cannabidiol Compositions For Anxiety Disorders

The present invention relates to pharmaceutical compositions of cannabidiol comprising less than 0.3% of THC for treating various anxiety disorders. The invention also discloses evaluation of efficacy, safety and pharmacokinetics of these compositions for treating mild to moderate anxiety disorders. ...

Trademarks